2020 Q1 Form 10-Q Financial Statement

#000113754720000013 Filed on May 01, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $9.494M $10.42M
YoY Change -8.86% 18.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $340.0K $360.0K
YoY Change -5.56% 9.09%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $761.0K $957.0K
YoY Change -20.48% 100.63%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.862M $5.630M
YoY Change -31.4% 26.86%
Income Tax $1.108M $1.623M
% Of Pretax Income 28.69% 28.83%
Net Earnings $2.754M $4.007M
YoY Change -31.27% 26.88%
Net Earnings / Revenue 29.01% 38.47%
Basic Earnings Per Share $0.16 $0.24
Diluted Earnings Per Share $0.16 $0.24
COMMON SHARES
Basic Shares Outstanding 16.97M shares 16.95M shares
Diluted Shares Outstanding 16.99M shares 16.97M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $199.9M $260.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.50M $12.80M
YoY Change -2.34% 26.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.600M $3.200M
YoY Change -18.75% 33.33%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $977.2M $964.0M
YoY Change 1.37% 12.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $100.0K
YoY Change 0.0% -98.57%
Accrued Expenses $3.300M $3.300M
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.400M $3.400M
YoY Change 0.0% -51.43%
LONG-TERM LIABILITIES
Long-Term Debt $8.500M $10.50M
YoY Change -19.05% 9.38%
Other Long-Term Liabilities $7.500M $7.400M
YoY Change 1.35%
Total Long-Term Liabilities $16.00M $17.90M
YoY Change -10.61% 86.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.400M $3.400M
Total Long-Term Liabilities $16.00M $17.90M
Total Liabilities $859.8M $852.8M
YoY Change 0.82% 13.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.4M $111.2M
YoY Change
Total Liabilities & Shareholders Equity $977.2M $964.0M
YoY Change 1.37% 12.78%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $2.754M $4.007M
YoY Change -31.27% 26.88%
Depreciation, Depletion And Amortization $340.0K $360.0K
YoY Change -5.56% 9.09%
Cash From Operating Activities $4.812M $2.823M
YoY Change 70.46% 6.97%
INVESTING ACTIVITIES
Capital Expenditures $242.0K -$110.0K
YoY Change -320.0% -63.33%
Acquisitions
YoY Change
Other Investing Activities -$43.92M $11.72M
YoY Change -474.74% 43.8%
Cash From Investing Activities -$44.16M $11.61M
YoY Change -480.47% 47.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $20.21M $25.93M
YoY Change -22.08% -44.73%
NET CHANGE
Cash From Operating Activities $4.812M $2.823M
Cash From Investing Activities -$44.16M $11.61M
Cash From Financing Activities $20.21M $25.93M
Net Change In Cash -$19.14M $40.36M
YoY Change -147.42% -29.7%
FREE CASH FLOW
Cash From Operating Activities $4.812M $2.823M
Capital Expenditures $242.0K -$110.0K
Free Cash Flow $4.570M $2.933M
YoY Change 55.81% -0.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001137547
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16974235 shares
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED SECURITY BANCSHARES
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
14000 USD
CY2020Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
15000 USD
CY2019Q1 ubfo Fair Value Option Credit Risk Gains Losseson Assets Netof Tax
FairValueOptionCreditRiskGainsLossesonAssetsNetofTax
-205000 USD
CY2020Q1 ubfo Fair Value Option Credit Risk Gains Losseson Assets Netof Tax
FairValueOptionCreditRiskGainsLossesonAssetsNetofTax
1587000 USD
CY2020Q1 ubfo Fair Value Option Credit Risk Gainson Assets Net
FairValueOptionCreditRiskGainsonAssetsNet
1055000 USD
CY2020Q1 ubfo Fair Value Option Credit Risk Gross Gainson Assets
FairValueOptionCreditRiskGrossGainsonAssets
1498000 USD
CY2019Q1 ubfo Fair Value Option Credit Risk Losseson Assets Net After Tax
FairValueOptionCreditRiskLossesonAssetsNetAfterTax
292000 USD
CY2019Q1 ubfo Fair Value Option Credit Risk Losseson Assets Net Before Tax
FairValueOptionCreditRiskLossesonAssetsNetBeforeTax
414000 USD
CY2019Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
982000 USD
CY2020Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
532000 USD
CY2019Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
0 USD
CY2020Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
179000 USD
CY2019Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2020Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2020Q1 ubfo Financing Receivable Modifications Numberof Contracts During Period2
FinancingReceivableModificationsNumberofContractsDuringPeriod2
1 contract
CY2020Q1 ubfo Financing Receivable Periodof Successful Payment History Usedfor Restructured Loan Accrual Status
FinancingReceivablePeriodofSuccessfulPaymentHistoryUsedforRestructuredLoanAccrualStatus
P6M
CY2019Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Credit Losses Write Offs
FinancingReceivablesImpairedTroubledDebtRestructuringCreditLossesWriteOffs
5000 USD
CY2020Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Credit Losses Write Offs
FinancingReceivablesImpairedTroubledDebtRestructuringCreditLossesWriteOffs
0 USD
CY2019Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Principal Additions Reductions
FinancingReceivablesImpairedTroubledDebtRestructuringPrincipalAdditionsReductions
714000 USD
CY2020Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Principal Additions Reductions
FinancingReceivablesImpairedTroubledDebtRestructuringPrincipalAdditionsReductions
112000 USD
CY2019Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
414000 USD
CY2020Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
1498000 USD
CY2020Q1 ubfo Lessee Financing Lease Number Of Contracts
LesseeFinancingLeaseNumberOfContracts
0 contract
CY2020Q1 ubfo Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
12 contract
CY2020Q1 ubfo Number Of General Segments For The Segregation Of Portfolio
NumberOfGeneralSegmentsForTheSegregationOfPortfolio
2 segment
CY2020Q1 ubfo Number Of Monthly Payments To Demonstrate Repayment Ability
NumberOfMonthlyPaymentsToDemonstrateRepaymentAbility
6 payment
CY2020Q1 ubfo Number Of Risk Rating Approaches
NumberOfRiskRatingApproaches
2 rating
CY2020Q1 ubfo Numberof Loan Portfolio Segment
NumberofLoanPortfolioSegment
10 segment
CY2020Q1 ubfo Numberof Loans Entity Experienced Losses
NumberofLoansEntityExperiencedLosses
3 loan
CY2019Q1 ubfo Operating Lease Rightof Use Asset Amortization
OperatingLeaseRightofUseAssetAmortization
-148000 USD
CY2020Q1 ubfo Operating Lease Rightof Use Asset Amortization
OperatingLeaseRightofUseAssetAmortization
-146000 USD
CY2020Q1 ubfo Period Of Default Minimum
PeriodOfDefaultMinimum
P90D
CY2019Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
93000 USD
CY2020Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
85000 USD
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101000 shares
CY2019Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
145000 USD
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
131000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
218995000 USD
CY2020Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
199853000 USD
CY2020Q1 ubfo Stockholders Equity Tax Benefit From Restricted Stock Units Released
StockholdersEquityTaxBenefitFromRestrictedStockUnitsReleased
1000 USD
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
60000 shares
CY2019Q4 us-gaap Assets
Assets
956919000 USD
CY2020Q1 us-gaap Assets
Assets
977246000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
80232000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
97486000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
272000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
461000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
521000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
834000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
76561000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94068000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260701000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199853000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40364000 USD
CY2019Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1868000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19142000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16973885 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16974235 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16973885 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16974235 shares
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3723000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3212000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
27233000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
23918000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
322000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
259000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
29361000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
35676000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
199000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
575000 USD
CY2019Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
56594000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
59594000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
521000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
834000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2019Q4 us-gaap Deposits
Deposits
818362000 USD
CY2020Q1 us-gaap Deposits
Deposits
840437000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1869000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1865000 USD
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1865000 USD
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
5187000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
5254000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1867000 USD
CY2018Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2019Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2019Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2019Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2019Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2020Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2883
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2869
CY2019Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
57000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15000 USD
CY2019Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
-291000 USD
CY2020Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
2253000 USD
CY2019Q4 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2020Q1 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8395000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8417000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7908000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9120000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6649000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8513000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1768000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
607000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-16000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
495000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
124000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
14000 USD
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
108000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
509000 USD
CY2019Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
561445000 USD
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
607849000 USD
CY2019Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
18455000 USD
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
15916000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
179000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
179000 USD
CY2018Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
7059000 USD
CY2019Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
6340000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 USD
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
610917000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 contract
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
386000 USD
CY2020Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1061000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
585019000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
11697000 USD
CY2020Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
12029000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
12355000 USD
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
12848000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
-109000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-65000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-153000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-113000 USD
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2020Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2019Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18570000 USD
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18125000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
16494000 USD
CY2019Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
138000 USD
CY2019 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
601000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
139000 USD
CY2019Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
43000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
81000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
17072000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
15916000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1145000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
607000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
17036000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
15901000 USD
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
14064000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
14003000 USD
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
3008000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1913000 USD
CY2019Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2020Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5630000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3862000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
761000 USD
CY2019Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
834000 USD
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
664000 USD
CY2019Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
123000 USD
CY2020Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
97000 USD
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
107000 USD
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
112000 USD
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10417000 USD
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9341000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
957000 USD
CY2019Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1298000 USD
CY2020Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
567000 USD
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9454000 USD
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6873000 USD
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9460000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8580000 USD
CY2019Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
477000 USD
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
428000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2995000 USD
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2772000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
261000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3878000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
725000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
440000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
657000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
665000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
656000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
735000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
561000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
840931000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
859836000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
956919000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
977246000 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10808000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8546000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
0 USD
CY2020Q1 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
0 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25934000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20207000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11607000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44161000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2823000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4812000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
4007000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
4097000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
4173000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
2895000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2754000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4007000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2754000 USD
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
5347000 USD
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
5591000 USD
CY2019Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
91000 USD
CY2020Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
94000 USD
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
1523000 USD
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
2580000 USD
CY2019Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
207000 USD
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
208000 USD
CY2019Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
579900000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
597374000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
623765000 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
588646000 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
614566000 USD
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
813000 USD
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
853000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
190000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3463000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
190000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3360000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0515
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M5D
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-284000 USD
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-182000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-513000 USD
CY2019Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-327000 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
458000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
4000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
6000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-403000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
650000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
-497000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
532000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
-705000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
755000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
-208000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
223000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-284000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
458000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
14000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
20000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
288000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-125000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
85000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-37000 USD
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
579000 USD
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
582000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1867000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1707000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
728000 USD
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
6000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3486000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3395000 USD
CY2019Q1 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
0 USD
CY2020Q1 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
201000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
895000 USD
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
813000 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
702000 USD
CY2019Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
6000 USD
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1707000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
809000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2019Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
99000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
95000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
78000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
77000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
78000 USD
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109240000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
111193000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
113338000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
115211000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
115988000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
117410000 USD
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
0 USD
CY2019Q4 us-gaap Trading Securities
TradingSecurities
0 USD
CY2020Q1 us-gaap Trading Securities
TradingSecurities
0 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
71000 USD
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25590 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20627 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16972630 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16994727 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16947040 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16974100 shares

Files In Submission

Name View Source Status
0001137547-20-000013-index-headers.html Edgar Link pending
0001137547-20-000013-index.html Edgar Link pending
0001137547-20-000013.txt Edgar Link pending
0001137547-20-000013-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ubfo-20200331.xml Edgar Link completed
ubfo-20200331.xsd Edgar Link pending
ubfo-2020033110q.htm Edgar Link pending
ubfo-20200331exhibit311.htm Edgar Link pending
ubfo-20200331exhibit312.htm Edgar Link pending
ubfo-20200331exhibit321.htm Edgar Link pending
ubfo-20200331exhibit322.htm Edgar Link pending
ubfo-20200331_cal.xml Edgar Link unprocessable
ubfo-20200331_def.xml Edgar Link unprocessable
ubfo-20200331_lab.xml Edgar Link unprocessable
ubfo-20200331_pre.xml Edgar Link unprocessable